Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2024

Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2024

Regular price
$75.00
Sale price
$75.00
Regular price
Sold out
Unit price
per 

2024 Course Overview






The Gastrointestinal, Liver, and Pancreatic Pathology course provides a broad overview of many areas of gastrointestinal, pancreatic, and hepatobiliary pathology and is presented by Harvard Medical School faculty and selected guest faculty with recognized expertise in the topic areas. The course is designed to update both academic practicing pathologists and those in the community with advances in gastrointestinal, pancreatic, and hepatobiliary pathology, and to provide aids in diagnosis based on conventional morphologic analysis, as well as updates on new staging criteria, new techniques such as novel immunohistochemistry markers, and molecular pathology data. Interactive learning formats, including didactic lectures, case seminars, and frequent discussion periods with extensive time for contact with faculty will be provided. The course will assist the learners in developing new strategies they can use in practice, leading to improved diagnoses, and better patient care.


Who Should Attend



  • Specialty Physicians

  • Allied Health Professionals


Learning Objectives


Describe the spectrum of benign and neoplastic gastrointestinal, pancreatic and liver disorders with emphasis on use of proper and up-to date nomenclature and criteria, and reporting findings of prognostic significance which meet current practice standards.


Upon completion of this activity, participants will be able to:



  • Evaluate gastrointestinal, pancreatic, and hepatobiliary cancers in the context of up-to-date grading and staging guidelines.

  • Evaluate difficult GI lesions with a better understanding of the relevant histologic features of those lesions, as well as the techniques that add value in their assessment.

  • Evaluate non-tumoral pathology of the GI tract and liver with a better understanding of the differential diagnosis, how to incorporate clinical information into that differential, and how to address the needs of clinical colleagues.






2024 Agenda






Information for the 2025 course is not yet available.


All agenda sessions are in Eastern Time.









Monday, May 6, 2024






DAY ONE


8:00-8:10 AM

Introduction/Welcome

Jonathan N. Glickman, MD, PhD; Mark Redston, MD







8:10-8:55 AM

Barrett’s Esophagus and Associated Neoplasia

Mark Redston, MD







8:55-9:25 AM

Clinician’s Perspective- Upper GI Tract

Kunal Jajoo, MD







9:25-9:35 AM

Q&A

Mark Redston, MD; Kunal Jajoo, MD







9:35-9:45 AM

Break







9:45-10:15 AM

Gastric Polyps and Precursor Lesions

Stuti Shroff, MBBS, PhD







10:15-10:45

Celiac Disease and its Differential Diagnosis

Jeffrey Goldsmith, MD







10:45-11:30 AM

Slide Seminar on Upper GI Tract

Miranda Machacek, MD, PhD







11:30-11:45 AM

Q&A

Jeffrey Goldsmith, MD; Miranda Machacek, MD, PhD; Stuti Shroff, MBBS, PhD







11:45 AM-12:45 PM

Lunch







12:45-1:15 PM

Biopsy Diagnosis of Colitis

Mark Redston, MD







1:15-1:45 PM

IBD: Controversies and Challenges

Michael G. Drage, MD, PhD







1:45-2:15 PM

Colon Polyps and Polyposis

Jonathan N. Glickman, MD, PhD







2:15-2:25 PM

Q&A

Mark Redston, MD; Michael G. Drage, MD, PhD; Jonathan N. Glickman, MD, PhD







2:25-2:35 PM

Break







2:35-3:05 PM

Molecular Diagnostics in Colon Cancer and Screening for Lynch Syndrome

Jonathan Nowak, MD, PhD







3:05-3:35 PM

Challenges in Colon Cancer Staging

Mark Redston, MD







3:35-4:20 PM

Slide Seminar: Lower GI

Jonathan N. Glickman, MD, PhD







4:20-4:30 PM

Q&A

Jonathan Nowak, MD, PhD; Mark Redston, MD; Jonathan N. Glickman, MD, PhD













Tuesday, May 7, 2024






DAY TWO


8:00-8:30 AM

GIST: From KIT to Succinate Dehydrogenase

Jason L. Hornick, MD, PhD







8:30-9:00 AM

Mesenchymal Tumors and Mesenchymal Polyps (other than GIST)

David Papke, MD, PhD







9:00-9:30 AM

Drug Induced Disorders of GI Tract

Mari Mino-Kenudson, MD







9:30-9:40 AM

Q&A

Mari Mino-Kenudson, MD; Jason L. Hornick, MD, PhD; David Papke, MD, PhD







9:40-9:50 AM

Break







9:50-10:20 AM

GI Lymphomas

Judith A. Ferry, MD







10:20-11:05 AM

Appendiceal Mucinous Neoplasms

Joseph Misdraji, MD







11:05-11:50 AM

Anal Pathology: Overview and Update

Jonathan N. Glickman, MD, PhD







11:50 AM-12:00 PM

Q&A

Judith A. Ferry, MD; Joseph Misdraji, MD; Jonathan N. Glickman, MD, PhD







12:00-1:00 PM

Lunch







1:00-1:45 PM

Endocrine Tumors of the Tubal Gut

Raul S. Gonzalez, MD







1:45-2:30 PM

Cytology and Small Biopsy Diagnosis of Pancreaticobiliary Tumors

Lisa Zhang, MD







2:30-2:40 PM

Q&A

Raul S. Gonzalez, MD; Lisa Zhang, MD







2:40-2:50 PM

Break







2:50-3:35 PM

Surgical Pathology of Pancreatic Tumors

Mari Mino-Kenudson, MD







3:35-4:05 PM

Biliary Tract Neoplasia

Stuti Shroff, MBBS, PhD







4:05-4:50 PM

Slide Seminar: Instructive Cases in Pancreatic Pathology

Esther Baranov, MD







4:50-5:00 PM

Q&A

Mari Mino-Kenudson, MD; Stuti Shroff, MBBS, PhD; Esther Baranov, MD













Wednesday, May 8, 2024






DAY THREE


8:00-8:30 AM

Medical Liver 1- Diagnostic Approach to Hepatitis

Angela Shih, MD







8:30-9:00 AM

Medical Liver 2- Fatty Liver

Lei Zhao, MD, PhD







9:00-9:30 AM

Clinician’s Perspective on Liver Biopsies

Daniel S. Pratt, MD







9:30-9:40 AM

Q&A

Angela Shih, MD; Lei Zhao, MD, PhD; Daniel S. Pratt, MD







9:40-10:00 AM

Break







10:00-10:45 AM

Liver Tumors

Rondell Graham, MBBS







10:45-11:15 AM

Medical Liver 3- Cholestatic Disorders

Angela Shih, MD







11:15 AM-12:00 PM

Case Seminar: Challenging Liver Cases

Lei Zhao, MD PhD







12:00-12:10 PM

Q&A

Lei Zhao, MD PhD; Angela Shih, MD; Rondell Graham, MBBS







12:10-12:20 PM

Concluding Remarks

Jonathan N. Glickman, MD, PhD; Mark Redston, MD







12:20-12:30 PM

Course Adjourns